Davis George Eric's Form 4 filing
Biomarin Pharmaceutical Inc (BMRN) · filed May 30, 2024
- Accession no.
- 0001048477-24-000112
- Filed
- May 30, 2024
- Trade date
- May 28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $3.04M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis George EricCIK 0001380710 | Officer (EVP, Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | Common Stock | MOption exerciseAcquired | +40,850 | $63.10 | +$2,577,635 | 97,007 | Direct | |
| May 28, 2024 | Common Stock | SSaleDisposed | −38,071 | $74.46 | −$2,834,766.66 | 58,936 | Direct | |
| May 28, 2024 | Common Stock | SSaleDisposed | −2,779 | $75.29 | −$209,230.91 | 56,157 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 28, 2024 | Common Stock | MOption exerciseDisposed | −40,850 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.